PMS Registry
Company Name
Protocol Number
Title of Study
XAMINA / Xarelto® on prevention of stroke and non-central nervous system systeMIc embolism in treatment Naïve Asian patients with non-valvular atrial fibrillation.
Primary Objective
The primary objective is to assess the safety of rivaroxaban regarding the rate of major bleeding in treatment naïve NVAF patients under clinical practice conditions.
Number of Sites
Period of Study
From:September 2017 to:September 2019
Number of Patients
IRB Approval Date
NTUH: 06/22/2017
NCKUH: 07/12/2017
CMUH: 07/13/2017
CCH: 07/29/2017
MMH: 07/31/2017
CMMC: 08/01/2017
VGHTC: 08/04/2017
KMUH: 08/10/2017
VGHTPE: 08/10/2017
CHGH: 09/16/2017
Publication Plan / Date
September 2020